FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+16.33%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$125M
AUM Growth
+$125M
(-23%)
Cap. Flow
-$45.4M
Cap. Flow
% of AUM
-36.2%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$6.28M |
Top Sells
| 1 |
Glaukos
GKOS
|
$50.6M |
| 2 |
Amicus Therapeutics
FOLD
|
$1.05M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBRA
1
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $33.5M | 26.73% | 2,668,570 | – | – |
|
|
2
Glaukos
GKOS
$5.5B
| $25.3M | 20.18% | 867,788 -1,735,574 | -67% | -$50.6M |
|
3
Collegium Pharmaceutical
COLL
$1.22B
| $22.4M | 17.84% | 1,887,332 | – | – |
|
|
4
Amicus Therapeutics
FOLD
$2.34B
| $14.9M | 11.87% | 2,725,591 -192,700 | -7% | -$1.05M |
|
5
Cidara Therapeutics
CDTX
$1.66B
| $13.5M | 10.79% | 1,312,258 | – | – |
|
|
6
Iovance Biotherapeutics
IOVA
$807M
| $6.28M | 5.01% | +774,720 | New | +$6.28M |
|
|
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
| $5.15M | 4.11% | 950,366 | – | – |
|
|
SRRA
8
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $4.35M | 3.47% | 2,186,195 | – | – |
|